To determine whether ERK1/2 affected the GCDA-induced survival of HCC cells, we designed siRNAs targeting ERK1 (225, 888, and 933) and ERK2 (355, 513, and 714). The gene discussed is MAPK3; the disease is hepatocellular carcinoma.